title: Nebivolol-induced gynecomastia.
abstract: Adverse drug reactions play a substantial role in the etiology of gynecomastia. Gynecomastia as an adverse drug reaction, related to some cardiovascular drugs, has been reported in literature. Nebivolol is a third generation beta-blocker, and gynecomastia as an adverse effect on the consumption of this drug has not been reported in any article yet. We herein present the case of a 42-year-old male, who developed bilateral gynecomastia following nebivolol use and complete regression after discontinuation of nebivolol. Other reasons causing gynecomastia were excluded. Discontinuation of the responsible drug is quite sufficient with regard to the treatment of drug-induced gynecomastia, without any pharmacological or surgical treatment.
authors: Department of Cardiology, Antalya Education and Research Hospital, Antalya, Turkey.
authors: Erkan
authors: E
authors: Köklü
authors: Department of Cardiology, Antalya Education and Research Hospital, Antalya, Turkey.
authors: Şakir
authors: Ş
authors: Arslan
authors: Department of Cardiology, Antalya Education and Research Hospital, Antalya, Turkey.
authors: İsa Öner
authors: İÖ
authors: Yüksel
authors: Department of Cardiology, Antalya Education and Research Hospital, Antalya, Turkey.
authors: Nermin
authors: N
authors: Bayar
authors: Department of Cardiology, Antalya Education and Research Hospital, Antalya, Turkey.
authors: Deniz
authors: D
authors: Demirci
keywords: Antihypertensive therapy; drug-induced gynecomastia; nebivolol